Craig Hallum started coverage on shares of Alterity Therapeutics (NASDAQ:ATHE – Get Free Report) in a research note issued on Tuesday. LADENBURG THALM/SH SH assumed coverage on Alterity Therapeutics in a research report on Tuesday, June 16th. Get Alterity Therapeutics alerts:View Our Latest Stock Analysis on Alterity TherapeuticsAlterity Therapeutics Stock PerformanceHedge Funds Weigh In On Alterity TherapeuticsAlterity Therapeutics stock opened at $4.58 on Tuesday. A hedge fund recently bought a new position in Alterity Therapeutics stock. Read MoreReceive News & Ratings for Alterity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.